ReadTheTrial indexes 5 studies for Relapsing Remitting Multiple Sclerosis. The most common development stage is Phase 2 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
5 clinical trials found for Relapsing Remitting Multiple Sclerosis.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 2 | 40% |
| N/A | 2 | 40% |
| Phase 4 | 1 | 20% |
There are 5 clinical trials listed for Relapsing Remitting Multiple Sclerosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Relapsing Remitting Multiple Sclerosis trials are distributed across: Phase 2 (2), N/A (2), Phase 4 (1).